The Role Intraoperative Salbutamol Inhaler in Preventing Atelectasis

Trial statusNot yet recruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age18-70
SponsorKing Abdullah University Hospital

About this trial

Atelectasis is considered a common complication in the perioperative period, especially following surgeries under general anesthesia. Postoperative atelectasis could occur anytime during the perioperative period from intraoperative period to 24 hours postoperative and contribute to a variety of other complications, including hypoxemia and pneumonia. In the literature, several methods were utilized to combat this phenomenon, therefore, we investigate the role of intraoperative salbutamol in reducing the incidence of atelectasis. It is well known that salbutamol could be an adjunctive bronchodilator medication used in the intraoperative anesthetic regimens.

Eligibility criteria

Qualifiers

The study will include patients aged 18-70 years

American Society of Anesthesiologists (ASA) physical status of I or II

Will undergo thoracic, abdominal or spinal surgery

Disqualifiers

cardiac conditions other than hypertension like arrhythmia

previous cardiac surgeries and valvular heart diseases

Trial design

Treatments tested in this trial

  • Salbutamol (Ventolin®)

Treatment groups

80 Participants
are divided into 4 treatment groups

Sponsors and collaborators

King Abdullah University Hospital

Lead sponsor

Jordan University of Science and Technology

Sponsor institution

Jordan University of Science and Technology

Collaborator